- Home
- ADAP vs NEUE Comparison
ADAP vs NEUE Comparison
Compare ADAP & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- NEUE
- Stock Information
- Founded
- ADAP 2008
- NEUE 2015
- Country
- ADAP United Kingdom
- NEUE United States
- Employees
- ADAP N/A
- NEUE N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- NEUE
- Sector
- ADAP Health Care
- NEUE
- Exchange
- ADAP Nasdaq
- NEUE NYSE
- Market Cap
- ADAP 75.5M
- NEUE 61.3M
- IPO Year
- ADAP 2015
- NEUE 2021
- Fundamental
- Price
- ADAP $0.27
- NEUE $6.80
- Analyst Decision
- ADAP Buy
- NEUE Hold
- Analyst Count
- ADAP 6
- NEUE 1
- Target Price
- ADAP $1.35
- NEUE $7.00
- AVG Volume (30 Days)
- ADAP 644.7K
- NEUE 7.6K
- Earning Date
- ADAP 08-11-2025
- NEUE 08-06-2025
- Dividend Yield
- ADAP N/A
- NEUE N/A
- EPS Growth
- ADAP N/A
- NEUE N/A
- EPS
- ADAP N/A
- NEUE N/A
- Revenue
- ADAP $179,639,000.00
- NEUE $907,349,000.00
- Revenue This Year
- ADAP N/A
- NEUE $33.99
- Revenue Next Year
- ADAP $35.48
- NEUE $5.90
- P/E Ratio
- ADAP N/A
- NEUE N/A
- Revenue Growth
- ADAP 878.53
- NEUE N/A
- 52 Week Low
- ADAP $0.20
- NEUE $3.79
- 52 Week High
- ADAP $1.48
- NEUE $7.66
- Technical
- Relative Strength Index (RSI)
- ADAP 56.59
- NEUE 46.55
- Support Level
- ADAP $0.23
- NEUE $6.79
- Resistance Level
- ADAP $0.28
- NEUE $6.89
- Average True Range (ATR)
- ADAP 0.02
- NEUE 0.07
- MACD
- ADAP 0.00
- NEUE -0.01
- Stochastic Oscillator
- ADAP 87.96
- NEUE 6.67
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.